Fort Worth, TX-The FDA will allow Alcon to add the words "Lasting Comfort" and new rinsing instructions to its Opti-Free Express multi-purpose disinfecting solution label.
Data demonstrates efficacy of FDA-approved therapy for treating amblyopia in children
ROP: Treating and preventing blindness in preterm babies
Vyluma meets with FDA to discuss atropine sulfate ophthalmic solution 0.01% for the treatment of pediatric myopia
Managing a changing landscape of IRD pediatric cases
Dopavision reports positive results from MyopiaX-1 trial on pediatric myopia management
Bipartisan proposal introduced in US House to address children's vision impairment